. 2013 Oct 18;8(10):e77738. doi: 10.1371/journal.pone.0077738

Table 3. Raw and adjusted mean most common lesion scores for the anterior, dorsal, lateral, and ventral prostate lobes (n = 28–33).

¹.

	Anterior prostate		Dorsal prostate		Lateral prostate		Ventral prostate
Group	Raw	Adjusted	Raw	Adjusted	Raw	Adjusted	Raw	Adjusted
Control	2.55 ± 0.36^a	6.75 ± 1.15^a	2.63 ± 0.23^a	7.41 ± 0.69^a	2.62 ± 0.32	7.42 ± 1.01^a	2.72 ± 0.37	7.52 ± 1.19^a
Pre-Finasteride	2.38 ± 0.41^a,b	6.23 ± 1.29^a,b	2.74 ± 0.47^a,b	7.43 ± 1.49^b,c	2.82 ± 0.47	7.70 ± 1.50^a,b	3.16 ± 0.50	8.64 ± 1.62^a,b
Post-Finasteride	2.33 ± 0.38^a,c	6.00 ± 1.19^a,c	2.82 ± 0.42^a,b	7.53 ± 1.26^a,b	2.88 ± 0.47	7.95 ± 1.48^a,b	2.95 ± 0.44	8.11 ± 1.41^a
Pre-Dutasteride	1.63 ± 0.27^b,c	3.72 ± 0.85^b,c	2.32 ± 0.43^b	6.06 ± 1.37^c	2.69 ± 0.46	7.02 ± 1.44^b	2.73 ± 0.46	7.06 ± 1.48^a,b
Post-Dutasteride	1.59 ± 0.27^b	3.68 ± 0.83^b	2.03 ± 0.33^b	5.08 ± 1.06^c	2.33 ± 0.40	5.95 ± 1.27^b	2.28 ± 0.41	5.72 ± 1.30^b

Data are mean ± SEM; values with different letters are statistically different (p<0.05).